Growth Hormone Treatment Completed Phase 2 / 3 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0043256 (Growth Hormone Treatment)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03038594
Growth Hormone Therapy for Muscle Regeneration in Severely Burned PatientsTreatment